embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results
25 oct. 2023 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, will host a conference call to discuss its fiscal fourth quarter and...
embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference
06 sept. 2023 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in a fireside chat at the Morgan Stanley 21st Annual...
Embecta Corp. Reports Third Quarter Fiscal 2023 Financial Results
08 août 2023 06h30 HE
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and...
embecta Announces Quarterly Cash Dividend
08 août 2023 06h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 08, 2023 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...
embecta to Report Fiscal Third Quarter 2023 Financial Results
11 juil. 2023 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, will host a conference call to discuss its fiscal third quarter 2023...
UPDATE -- embecta to Participate in Investor Conferences
15 mai 2023 17h38 HE
|
Embecta Corp.
PARSIPPANY, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will...
embecta to Participate in Investor Conferences
15 mai 2023 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will...
Embecta Corp. Reports Second Quarter Fiscal 2023 Financial Results
12 mai 2023 06h30 HE
|
Embecta Corp.
PARSIPPANY, N.J., May 12, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported...
embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes
12 mai 2023 06h15 HE
|
Embecta Corp.
PARSIPPANY, N.J. and PALO ALTO, Calif., May 12, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, and Tidepool, a...
embecta Announces Quarterly Cash Dividend
12 mai 2023 06h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., May 12, 2023 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (NASDAQ: EMBC) have declared a quarterly cash dividend of $0.15 for each issued and outstanding...